Nanoparticles and microparticles as vaccine-delivery systems (Q36968297)

17 August 2017

1 reference

title

Nanoparticles and microparticles as vaccine-delivery systems (English)

1 reference

17 August 2017

1 reference

1 reference

Manmohan Singh

1

1 reference

17 August 2017

Aravind Chakrapani

series ordinal

2

1 reference

17 August 2017

Derek O'Hagan

series ordinal

3

1 reference

17 August 2017

language of work or name

1 reference

1 October 2007

1 reference

Expert Review of Vaccines

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

5

1 reference

17 August 2017

797-808

1 reference

Challenges facing adjuvants for cancer immunotherapy

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Aluminium compounds for use in vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Microparticles as vaccine adjuvants and delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Seeking wisdom in innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Microparticles and Nanoparticles as Delivery Systems for DNA Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

A practical approach to the use of nanoparticles for vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Cationic microparticles: A potent delivery system for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Size effect on the antibody production induced by biodegradable microspheres containing antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Microparticles and nanoparticles for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Biodegradable microspheres in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Improving protein therapeutics with sustained-release formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

A month-long effect from a single injection of microencapsulated human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Ambiguities in the preclinical quality assessment of microparticulate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Microparticle-based technologies for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

A single-step immunization by sustained antigen release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Development of a novel vaccine delivery system based on Gantrez nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Implication of nanoparticles/microparticles in mucosal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Microparticle vaccine approaches to stimulate mucosal immunisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Oral particulate delivery: status and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Characterisation and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.797

21 January 2018

Identifiers

DOI

10.1586/14760584.6.5.797

1 reference

17 August 2017

1 reference